Illumina Stock to Gain From the Launch of New DRAGEN v4.4 SoftwareZacks Investment Research • 05/20/25
Signios Bio and Illumina Announce Grant to Maximize Discovery Power with Industry's Largest NGS-Based Proteomics PanelBusiness Wire • 05/19/25
Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%Benzinga • 05/16/25
Investing in Illumina (ILMN)? Don't Miss Assessing Its International Revenue TrendsZacks Investment Research • 05/13/25
Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applicationsPRNewsWire • 05/13/25
Illumina Q1 Earnings Top Estimates, Revenues Down Y/Y, Stock DipsZacks Investment Research • 05/09/25
Unveiling Illumina (ILMN) Q1 Outlook: Wall Street Estimates for Key MetricsZacks Investment Research • 05/05/25
Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy developmentPRNewsWire • 05/01/25
Target Validation for Genetic Targets Innovation Research Report 2025: 14,172 Deals Totaling $11.4 Billion - BGI biotech and illumina are Among the Leaders with Strong PortfoliosGlobeNewsWire • 04/18/25
Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovationPRNewsWire • 04/15/25
Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025PRNewsWire • 04/10/25
Corvex's Meister joins the board at Illumina. Here's how he can create value for shareholdersCNBC • 03/29/25
How Tariffs Are Rocking The 'Bubblegum And Shoestring' Medical Supply ChainInvestors Business Daily • 03/27/25
Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of DirectorsPRNewsWire • 03/25/25
Illumina's AGD Project Completes 250,000 Whole Genomes: Stock to Gain?Zacks Investment Research • 03/24/25
Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discoveryPRNewsWire • 03/19/25